BIOMAT Database Logo BIOMAT Database Logo

Neutrophil elastase inhibitor reduces neutrophil chemoattractant production after ischemia-reperfusion in rat liver. 1997

Y Yamaguchi, and E Akizuki, and O Ichiguchi, and F Matsumura, and M Goto, and N Miyanari, and K Mori, and S Yamada, and M Ogawa
Department of Surgery II, Kumamoto University Medical School, Japan.

OBJECTIVE Neutrophils are important in the development of tissue injury induced by ischemia-reperfusion. The ability of an inhibitor of neutrophil elastase (ONO-5046) to protect against ischemia-reperfusion injury in rat liver was investigated by measuring serum concentrations of cytokine-induced neutrophil chemoattractant. METHODS Liver ischemia was induced in rats by occluding the portal vein for 30 minutes, and ONO-5046 or anticoagulants were injected intravenously 5 minutes before vascular clamping. RESULTS Serum concentration of cytokine-induced neutrophil chemoattractant increased after reperfusion, reached a maximum at 6 hours, and then gradually decreased. However, pretreatment of animals with heparin (50 U/kg), antithrombin III (250 U/kg), or ONO-5046 (10 mg/kg) resulted in significantly smaller increases in the serum concentration of cytokine-induced neutrophil chemoattractant after reperfusion. Pretreatment with both ONO-5046 and heparin, or both ONO-5046 and antithrombin III, produced additive effects. Pretreatment of rats with both ONO-5046 and heparin or both ONO-5046 and antithrombin III also inhibited the increase in cytokine-induced neutrophil chemoattractant mRNA in liver. These combined treatments significantly reduced the increases in both the number of neutrophils accumulated in the liver and the hepatic activity of myeloperoxidase. CONCLUSIONS Cytokine-induced neutrophil chemoattractant production after ischemia-reperfusion in the liver is mediated by neutrophil elastase and activation of coagulation within the hepatic microcirculation.

UI MeSH Term Description Entries
D007511 Ischemia A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION. Ischemias
D007958 Leukocyte Count The number of WHITE BLOOD CELLS per unit volume in venous BLOOD. A differential leukocyte count measures the relative numbers of the different types of white cells. Blood Cell Count, White,Differential Leukocyte Count,Leukocyte Count, Differential,Leukocyte Number,White Blood Cell Count,Count, Differential Leukocyte,Count, Leukocyte,Counts, Differential Leukocyte,Counts, Leukocyte,Differential Leukocyte Counts,Leukocyte Counts,Leukocyte Counts, Differential,Leukocyte Numbers,Number, Leukocyte,Numbers, Leukocyte
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008102 Liver Circulation The circulation of BLOOD through the LIVER. Hepatic Circulation,Circulation, Liver,Circulation, Hepatic
D008297 Male Males
D009195 Peroxidase A hemeprotein from leukocytes. Deficiency of this enzyme leads to a hereditary disorder coupled with disseminated moniliasis. It catalyzes the conversion of a donor and peroxide to an oxidized donor and water. EC 1.11.1.7. Myeloperoxidase,Hemi-Myeloperoxidase,Hemi Myeloperoxidase
D009504 Neutrophils Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. LE Cells,Leukocytes, Polymorphonuclear,Polymorphonuclear Leukocytes,Polymorphonuclear Neutrophils,Neutrophil Band Cells,Band Cell, Neutrophil,Cell, LE,LE Cell,Leukocyte, Polymorphonuclear,Neutrophil,Neutrophil Band Cell,Neutrophil, Polymorphonuclear,Polymorphonuclear Leukocyte,Polymorphonuclear Neutrophil
D002630 Chemotactic Factors Chemical substances that attract or repel cells. The concept denotes especially those factors released as a result of tissue injury, microbial invasion, or immunologic activity, that attract LEUKOCYTES; MACROPHAGES; or other cells to the site of infection or insult. Chemoattractant,Chemotactic Factor,Chemotaxin,Chemotaxins,Cytotaxinogens,Cytotaxins,Macrophage Chemotactic Factor,Chemoattractants,Chemotactic Factors, Macrophage,Macrophage Chemotactic Factors,Chemotactic Factor, Macrophage,Factor, Chemotactic,Factor, Macrophage Chemotactic
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D005998 Glycine A non-essential amino acid. It is found primarily in gelatin and silk fibroin and used therapeutically as a nutrient. It is also a fast inhibitory neurotransmitter. Aminoacetic Acid,Glycine, Monopotassium Salt,Glycine Carbonate (1:1), Monosodium Salt,Glycine Carbonate (2:1), Monolithium Salt,Glycine Carbonate (2:1), Monopotassium Salt,Glycine Carbonate (2:1), Monosodium Salt,Glycine Hydrochloride,Glycine Hydrochloride (2:1),Glycine Phosphate,Glycine Phosphate (1:1),Glycine Sulfate (3:1),Glycine, Calcium Salt,Glycine, Calcium Salt (2:1),Glycine, Cobalt Salt,Glycine, Copper Salt,Glycine, Monoammonium Salt,Glycine, Monosodium Salt,Glycine, Sodium Hydrogen Carbonate,Acid, Aminoacetic,Calcium Salt Glycine,Cobalt Salt Glycine,Copper Salt Glycine,Hydrochloride, Glycine,Monoammonium Salt Glycine,Monopotassium Salt Glycine,Monosodium Salt Glycine,Phosphate, Glycine,Salt Glycine, Monoammonium,Salt Glycine, Monopotassium,Salt Glycine, Monosodium

Related Publications

Y Yamaguchi, and E Akizuki, and O Ichiguchi, and F Matsumura, and M Goto, and N Miyanari, and K Mori, and S Yamada, and M Ogawa
Neutrophil elastase and oxygen radicals enhance monocyte chemoattractant protein- expression after ischemia/reperfusion in rat liver.
November 1999, Transplantation,
Y Yamaguchi, and E Akizuki, and O Ichiguchi, and F Matsumura, and M Goto, and N Miyanari, and K Mori, and S Yamada, and M Ogawa
Thrombin and factor Xa enhance neutrophil chemoattractant production after ischemia/reperfusion in the rat liver.
July 2000, The Journal of surgical research,
Y Yamaguchi, and E Akizuki, and O Ichiguchi, and F Matsumura, and M Goto, and N Miyanari, and K Mori, and S Yamada, and M Ogawa
Effect of specific neutrophil elastase inhibitor on ischemia/reperfusion injury in rat liver transplantation.
September 1999, The Journal of surgical research,
Y Yamaguchi, and E Akizuki, and O Ichiguchi, and F Matsumura, and M Goto, and N Miyanari, and K Mori, and S Yamada, and M Ogawa
The protective function of neutrophil elastase inhibitor in liver ischemia/reperfusion injury.
May 2010, Transplantation,
Y Yamaguchi, and E Akizuki, and O Ichiguchi, and F Matsumura, and M Goto, and N Miyanari, and K Mori, and S Yamada, and M Ogawa
Anticoagulant pretreatment attenuates production of cytokine-induced neutrophil chemoattractant following ischemia-reperfusion of rat liver.
July 1996, Digestive diseases and sciences,
Y Yamaguchi, and E Akizuki, and O Ichiguchi, and F Matsumura, and M Goto, and N Miyanari, and K Mori, and S Yamada, and M Ogawa
Urinary trypsin inhibitor reduces C-X-C chemokine production in rat liver ischemia/reperfusion.
December 2000, The Journal of surgical research,
Y Yamaguchi, and E Akizuki, and O Ichiguchi, and F Matsumura, and M Goto, and N Miyanari, and K Mori, and S Yamada, and M Ogawa
Neutrophil elastase inhibitor, sivelestat sodium hydrate prevents ischemia-reperfusion injury in the rat bladder.
April 2008, Molecular and cellular biochemistry,
Y Yamaguchi, and E Akizuki, and O Ichiguchi, and F Matsumura, and M Goto, and N Miyanari, and K Mori, and S Yamada, and M Ogawa
A synthetic selective inhibitor of factor Xa, DX-9065a, reduces monocyte chemoattractant protein-1 expression after ischemia-reperfusion injury in rat liver.
December 1999, Digestive diseases and sciences,
Y Yamaguchi, and E Akizuki, and O Ichiguchi, and F Matsumura, and M Goto, and N Miyanari, and K Mori, and S Yamada, and M Ogawa
Benefical effect of neutrophil elastase inhibitor on renal warm ischemia-reperfusion injury in the rat.
September 2006, Transplantation proceedings,
Y Yamaguchi, and E Akizuki, and O Ichiguchi, and F Matsumura, and M Goto, and N Miyanari, and K Mori, and S Yamada, and M Ogawa
Effects of neutrophil elastase inhibitor (ONO-5046) on lung injury after intestinal ischemia-reperfusion.
October 2001, Journal of applied physiology (Bethesda, Md. : 1985),
Copied contents to your clipboard!